Expression of the antiapoptotic gene survivin in chronic myeloid leukemia

Anticancer Research

Volumn 23, Issue 1 B, 2003, Pages 589-592

  Badran, Adel ^a   Yoshida, Akira ^a   Yujiwano, ^b   Imamura, Shin ^a   Kawai, Yasukazu ^a   Tsutani, Hiroshi ^a   Inuzuka, Manabu ^a   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; CML; Ph chromosome; RT PCR; Survivin

Indexed keywords

BETA ACTIN; INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN;

APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LEUKEMOGENESIS; NUCLEOTIDE SEQUENCE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PHILADELPHIA CHROMOSOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037231171     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Uren AG, Coulson EJ and Vaux DL: Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem Sci 23: 159-62, 1998.
2. Rothe M, Pan MG, Henzel WJ, Ayres TM and Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-52, 1995.
3. Hinds MG, Norton RS, Vaux DL and Day CL: Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol 6: 648-51, 1999.
4. Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
5. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
6. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-21, 1997.
7. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC: Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1: 461-6, 1999.
8. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A and Abad A: A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17: 2100-4, 1999.
9. Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46: 645-50, 2000.
10. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T and Suzuki A: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31: 1080-5, 2000.
11. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A and Shimosegawa T: Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92: 271-8, 2001.
12. Swana HS, Grossman D, Anthony JN, Weiss RM and Altieri DC: Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341: 452-3, 1999.
13. Xing N, Qian J, Bostwick D, Bergstralh E and Young CY: Neuroendocrine cells in human prostate over-express the antiapoptosis protein survivin. Prostate 48: 7-15, 2001.
14. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-34, 2000.
15. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y and Nakagawara A: High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-23, 2000.
16. Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC and Dombret H: Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111: 196-203, 2000.
17. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC and Molina TJ: Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96: 1921-5, 2000.
18. Moriai R, Asanuma K, Kobayashi D, Yajima T, Yagihashi A, Yamada M, Watanade N: Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 21: 595-600, 2001.
19. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-20, 1998.
20. Shinozawa I, Inokuchi K, Kawabayashi I and Dan K: Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies. Leuk Res 24: 965-70, 2000.
21. Mori A, Wada H, Nishimura Y, Okamoto T, Takemoto Y and Kakishita E: Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 75: 161-5, 2002.
22. Yoshida A, Kishi S, Kita K, Kamada N, Nakamura T and Ueda T: Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia. Anticancer Res 17: 625-28, 1997.
23. Kurzrock R, Gutterman JU and Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319: 990-98, 1988.
24. Shtivelman E, Lifshitz B, Gale RP and Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315: 550-54, 1985.
25. Konopka JB, Watanabe SM, Singer JW, Collins SJ and Witte ON: Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci USA 82: 1810-14, 1985.
26. Daley GQ, Van Etten RA and Baltimore D: Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247: 824-30, 1990.
27. Lugo TG, Pendergast AM, Muller AG and Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247: 1079-82, 1990.
28. Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa s, Ishikawa T, Yazaki Y and Hirai H: Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. Blood 95: 1144-50, 2000.
29. Ceballos E, Delgado MD, Gutierrez P, Richard C, Muller D, Eilers M, Ehinger M, Gullberg U and Leon J: c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene 19: 2194-204, 2000.
30. Hehlmann R, Heimpel H, Griesshammer M, Kolb HJ, Heinze B, Hossfeld DK, Wickramanayake PD, Essers U, Thiele J, Georgii A et al: Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group. Leukemia 3: 110S-114S, 1992.
31. Cortes JE, Talpaz M, Beran M, O'Brien SM, Rios MB, Stass S and Kantarjian HM: Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results. Cancer 75: 464-70, 1995.
32. Hernandez JM, del Canizo MC, Cuneo A, Garcia JL, Gutierrez NC, Gonzalez M, Castoldi G and San Miguel JF: Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 11: 441-4, 2000.
33. Cogswell PC, Morgan R, Dunn M, Neubauer A, Nelson P, Poland- Johnston NK, Sandberg AA and Liu E: Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia. Blood 74: 2629-33, 1989.
34. Kantarjian HM, Kurzrock R and Talpaz M: Philadelphia chromosome negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am 4: 389-404, 1990.
35. Martiat P, Michaux JL and Rodhain J: Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique. Blood 78: 205-11, 1991.
36. Oscier DG: Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol 92: 582-6, 1996.